Comparative analysis of mitochondrial proteomes across the tree of life

[THEO] Okay, picture this. You've got a tiny microbe swimming around, minding its own business, and another cell just... swallows it. But doesn't digest it. Instead, they move in together. Permanently. That's the origin story of the mitochondrion — the thing powering basically every cell in your body right now.

[DR. MARA] Roughly two billion years ago, give or take. A free-living bacterium, likely an alphaproteobacterium, ends up inside an archaeal-type host cell. And instead of becoming lunch, it becomes an organelle. The endosymbiotic theory.

[THEO] And the wild part is the evidence is still sitting in your cells. Mitochondria have their own little genome.

[DR. MARA] They do. But it's a shadow of the original. The ancestor had thousands of genes. Modern human mitochondria carry thirteen protein-coding genes. The rest got transferred to the nucleus over evolutionary time, or lost entirely. So most mitochondrial proteins — well over a thousand — are encoded in the nucleus, made in the cytoplasm, and shipped back in.

[THEO] So the organelle outsourced its own payroll to headquarters.

[DR. MARA] That's not a bad way to put it. And that genome reduction is the fingerprint of the transition from symbiont to organelle. The question people have fought over is when it happened. Early, defining the eukaryotic cell? Or later, after a lot of complexity was already in place?

[THEO] And how do you even measure "what's in a mitochondrion"? Because you can't just read the DNA — most of the proteins are coded elsewhere.

[DR. MARA] Right, so you need the proteome, not just the genome. You purify mitochondria, run mass spectrometry, and build an inventory of which proteins actually live there. For humans that's been done — it's called MitoCarta, roughly sixteen hundred fifty proteins. The new work extends that across the eukaryotic tree.

[THEO] This is the Mootha group — the paper's called MitoCartaTOL, "tree of life." Six lineages?

[DR. MARA] Six. And the range is striking. At one extreme, *Giardia* — an intestinal parasite. Its mitochondrion is a vestigial remnant. Fifty-nine proteins. No energy-producing capacity at all.

[THEO] Fifty-nine! Versus sixteen hundred in us. The powerhouse of the cell that forgot how to make power.

[DR. MARA] It kept a few housekeeping functions — iron-sulfur cluster assembly, for one — and dumped the rest. At the other extreme, the kinetoplastids. *Trypanosoma*, *Leishmania* — the parasites behind sleeping sickness and leishmaniasis. Their mitochondrial proteomes run about fifty percent larger than the human baseline.

[THEO] So these organisms took the same organelle and went in opposite directions — one gutted it, one supersized it.

[DR. MARA] Which tells you the mitochondrion is still actively evolving, lineage by lineage. It isn't a frozen fossil.

[THEO] And the timing question — you said people argue about early versus late. What did the phylogenetics say?

[DR. MARA] They built a maximum-likelihood reconstruction, and it points to the organelle arising relatively late — after other complex cellular machinery was already established. I'd flag that this is a reconstruction, an inference from present-day proteomes, not a time machine. But it leans against the "mitochondria made the eukaryote" story.

[THEO] Which is genuinely contested territory, so — one study, not the final word.

[DR. MARA] Exactly. Where it gets practical: those kinetoplastid parasites have mitochondrial biology wildly different from ours. Different proteins, different machinery. That's a target list for drugs that hit the parasite and spare the human host.

[THEO] Find the parts of their power plant we don't have, and jam those specifically.

[DR. MARA] A clean selectivity principle, if the biology cooperates.

[THEO] Comparative proteomics as a map for both evolution and medicine. We'll be right back after this.